Shekel Brainweigh Ltd.

As of December 31, 2023, Shekel Brainweigh Ltd. has 203.29M shares outstanding.

These figures are as of December 31, 2023. The EV/Sales ratio of 0.71 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Shekel Brainweigh Ltd. trades at an EV/FCF ratio of 12.35, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2023, Shekel Brainweigh Ltd. maintains a current ratio of 0.68, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -408.21, indicating conservative leverage, while an interest coverage ratio of -3.31 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) is negative at -23.85, reflecting losses generated across the asset base. Inventory turnover of 3.70 indicates how many times Shekel Brainweigh Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2023, Shekel Brainweigh Ltd. posted a gross margin of 33.67, reflecting its pricing power and cost economics. The operating margin of -14.45 and net profit margin of -21.01 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2023. The dividend payout ratio of -0.70 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

As of December 31, 2023, Shekel Brainweigh Ltd. has an Altman Z-Score of -1.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.